Compare Endeavour Silver Corp (EXK) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Endeavour Silver Corp vs TransMedics Group Inc — how do they compare? Endeavour Silver Corp trades at $8.65 (market cap $2.54B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: Endeavour Silver Corp and TransMedics Group Inc are close in size by market cap, and TransMedics Group Inc is more actively traded (949,331 versus 7,077,330). Which is the better fit depends on your goals — on Pluang, investors hold Endeavour Silver Corp for 25 Days and TransMedics Group Inc for 24 Days on average.
| EXK | TMDX | |
|---|---|---|
Market Cap | $2.54B | $2.74B |
Volume | 7,077,330 | 949,331 |
Sector | Basic Materials | Health |
52-Week High | $14.12 | $150.42 |
52-Week Low | $7.07 | $61.99 |
Typical Hold Time | 25 Days | 24 Days |
Enterprise Value | $2.54B | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Endeavour Silver (EXK) trades at $8.57, up 3.0% today, amid a bearish technical signal from moving averages but with neutral oscillators. The company reported a net loss of $119.10 million in 2025, though 2026 projections show a turnaround to a $66 million profit. Recent news highlights operational progress at the Terronera and Kolpa mines, alongside temporary disruptions now resolved. Revenue grew from $467.50 million in 2025 to a projected $737 million in 2026, signaling strong operational expansion.
The outlook for EXK is cautiously optimistic, driven by production growth and favorable silver prices, but risks include operational volatility and high valuation multiples. Analysts are predominantly bullish, with 11 of 14 recommending Buy, citing the company's strategic mine developments and improving financial trajectory as key catalysts for potential upside.
TransMedics Group (TMDX) trades at $79.00, down 2.55% amid bearish technical signals and mixed earnings performance. The stock shows strong fundamentals with 58.69% gross margins and 22.69% net income margins, though profitability declined year-over-year. Recent news highlights insider buying, CFO appointment, and ongoing legal investigations into fiduciary duties, creating conflicting sentiment signals.
While analyst consensus remains bullish with a $99.75 price target, near-term risks include margin pressure from heavy investments and legal uncertainties. The stock's current valuation at 20.47 P/E offers potential upside if execution improves, but investors face volatility from earnings misses and regulatory scrutiny.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Endeavour Silver Corp
Endeavour Silver is a mid-tier precious metals mining company. It operates silver-gold mines in Mexico and is focused on growing its production and reserves through exploration and the development of new mining projects.
Read more on EXK →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
